0001562180-23-005321.txt : 20230620
0001562180-23-005321.hdr.sgml : 20230620
20230620075727
ACCESSION NUMBER: 0001562180-23-005321
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230616
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MATLIN DAVID J
CENTRAL INDEX KEY: 0001251956
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39834
FILM NUMBER: 231023419
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clene Inc.
CENTRAL INDEX KEY: 0001822791
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 852828339
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
BUSINESS PHONE: 801-676-9695
MAIL ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
FORMER COMPANY:
FORMER CONFORMED NAME: Chelsea Worldwide Inc.
DATE OF NAME CHANGE: 20200827
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-06-16
false
0001822791
Clene Inc.
CLNN
0001251956
MATLIN DAVID J
6550 SOUTH MILLROCK DRIVE
SUITE G50
SALT LAKE CITY
UT
84121
true
false
false
false
false
Common Stock
2023-06-16
4
P
false
1500000.00
0.80
A
6793684.00
D
Common Stock
150000.00
I
By Trust
Warrants (Right to buy)
1.50
2023-06-16
4
A
false
1500000.00
A
2023-06-16
Common Stock
1500000.00
1500000.00
D
Warrants (Right to buy)
1.10
2023-06-16
4
A
false
1500000.00
A
2023-06-16
Common Stock
1500000.00
1500000.00
D
The securities are owned by the Matlin Family Trust 2020. Mr. Matlin in the trustee of the Matlin Family Trust 2020. The shares owned by the Matlin Family Trust 2020 may be deemed to be beneficially owned by Mr. Matlin.
The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant.
The reporting person purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche B Warrant is for 1,500,000 shares of Common Stock of Clene Inc. at an exercise price of $1.50 per share. The Tranche B Warrant will expire on the earlier of (a) June 16, 2030, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc.
The reporting person purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche A Warrant is for 1,500,000 shares of Common Stock of Clene Inc. at an exercise price of $1.10 per share. The Tranche A Warrant will expire on the earlier of (a) June 16, 2026, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc.
/s/ Jerry Miraglia POA
2023-06-20